How Pulmonary Hypertension and Scleroderma Are Connected

In this video from PAH.TV, find out how pulmonary hypertension and the autoimmune disease, scleroderma, are connected.

MORE: Tracleer may delay the onset of pulmonary hypertension in scleroderma patients. 

The national director of development and research for the Scleroderma Foundation, Tracy Sperry, talks about the non-profit organization at the American Thoracic Society meeting in San Diego, California. She also explains how scleroderma is a disease that causes an overproduction of collagen which can lead to thickening and scarring of organs such as the lungs.

Many scleroderma patients develop pulmonary hypertension (PH) or interstitial lung disease (ILD), and lung involvement in scleroderma is the leading cause of death for patients.

MORE: Likelihood of PAH in scleroderma patients may be evident in specific autoantibodies.

Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.